Newly formed US subsidiary, good news, we are serious about devloping the US market.

The distribution agreement was entered into between Response Biomedical's newly formed, wholly owned U.S. subsidiary Response Point of Care Inc. and LABSCO for an initial term of three years and is renewable annually thereafter upon mutual agreement. LABSCO will initially market Response's cardiovascular POC test panels on the RAMP(R) Reader in all settings and on the RAMP(R) 200 reader in laboratory settings. Response will continue to market the cardiovascular POC test panel on both the RAMP(R) 200 reader and RAMP(R) Reader outside the US, and the RAMP(R) Flu A+B Assay and RAMP(R) RSV Assay on the RAMP(R) 200 reader globally where approved for sale by relevant regulatory authorities.